NYSE · CIK 0000814083
CLM Cornerstone Strategic Investment Fund, Inc.
Insider trading from SEC Form 4. Last filing 41 d ago. Close $6.59 on Oct 9, 2026, +5% from the 52-week low and -10% from the high.
Last 90 days
Net insider value
+$9,945
more bought than sold
Buys
1
$9,945 by 1 insider
Sells
0
$0 by 0 insiders
Insiders on file
3
with a Form 4 at this company
Price and insider trades, last year
CLMOct 9, 2026 · close 6.59
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Cornerstone Strategic Investment Fund, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 23Weak | Peter Greer director buy | $9,945 1,500 shares | - | - | |
| 15Weak | Matthew Morris director sell | $6 1 shares | -0% | +34% from low-0% from high | |
| 29Weak | Matthew Morris director sell | $285k 35,000 shares | - | +33% from low-0% from high |
Transactions
The last 4 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | Peter Greer director | POpen-market purchase Common Stock | +1,500 | $6.63 | $9,945 | 1,500 | 41 d ago |
| Sep 10, 2025 | Matthew Morris director | SOpen-market sale Common Stock | -1 | $8.18 | $6 | 26,193 | Sep 11, 2025 |
| Sep 3, 2025 | Matthew Morris director | SOpen-market sale Common Stock | -35,000 | $8.14 | $285k | - | Sep 5, 2025 |
| May 22, 2025 | Ralph W Bradshaw President | MOption exercise Common Stock | +2,554 | $7.30 | $19k | 19,293 | May 27, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Ralph W BradshawPresident
- Peter Greerdirector
- Matthew Morrisdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.